Loading…
GE Healthcare opened a biotechnology manufacturing center at the Stevenage Bioscience Catalyst campus in Stevenage, UK, which will produce a fiber-based biopharmaceutical purification platform from the first half of 2019.
“In the first half of 2019, the center will start producing a fiber-based purification platform, which has the potential to significantly improve efficiency in the purification steps of manufacturing biopharmaceuticals, gene therapies and viral vectors.”stevenagecatalyst.com
Summarized from public sources; check the original articles before acting on it.